91 related articles for article (PubMed ID: 9335414)
21. Leisure time physical activity and insulin resistance in young obese students with hypertension.
Saito I; Nishino M; Kawabe H; Wainai H; Hasegawa C; Saruta T; Nagano S; Sekihara T
Am J Hypertens; 1992 Dec; 5(12 Pt 1):915-8. PubMed ID: 1285941
[TBL] [Abstract][Full Text] [Related]
22. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
Freemark M; Bursey D
Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
[TBL] [Abstract][Full Text] [Related]
23. Metabolic neutrality of perindopril: focus on insulin sensitivity in overweight patients with essential hypertension.
Böhlen L; Bienz R; Doser M; Papiri M; Shaw S; Riesen W; Weidmann P
J Cardiovasc Pharmacol; 1996 Jun; 27(6):770-6. PubMed ID: 8761842
[TBL] [Abstract][Full Text] [Related]
24. Dehydroepiandrosterone decreases serum tumor necrosis factor-alpha and restores insulin sensitivity: independent effect from secondary weight reduction in genetically obese Zucker fatty rats.
Kimura M; Tanaka S; Yamada Y; Kiuchi Y; Yamakawa T; Sekihara H
Endocrinology; 1998 Jul; 139(7):3249-53. PubMed ID: 9645700
[TBL] [Abstract][Full Text] [Related]
25. Long-term metabolic effects of antihypertensive drugs.
Lind L; Pollare T; Berne C; Lithell H
Am Heart J; 1994 Dec; 128(6 Pt 1):1177-83. PubMed ID: 7985599
[TBL] [Abstract][Full Text] [Related]
26. [The relationship between androgens concentrations (testosterone and dehydroepiandrosterone sulfate) and metabolic syndrome in non-obese elderly men].
Rabijewski M; Papierska L; Kozakowski J; Zgliczyński W
Endokrynol Pol; 2007; 58(6):496-504. PubMed ID: 18205106
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the effects of barnidipine+losartan compared with telmisartan+hydrochlorothiazide on several parameters of insulin sensitivity in patients with hypertension and type 2 diabetes mellitus.
Derosa G; Querci F; Franzetti I; Dario Ragonesi P; D'Angelo A; Maffioli P
Hypertens Res; 2015 Oct; 38(10):690-4. PubMed ID: 25994603
[TBL] [Abstract][Full Text] [Related]
28. Effect of dehydroepiandrosterone replacement on insulin sensitivity and lipids in hypoadrenal women.
Dhatariya K; Bigelow ML; Nair KS
Diabetes; 2005 Mar; 54(3):765-9. PubMed ID: 15734854
[TBL] [Abstract][Full Text] [Related]
29. Metabolic and cardiovascular effects of carvedilol and atenolol in non-insulin-dependent diabetes mellitus and hypertension. A randomized, controlled trial.
Giugliano D; Acampora R; Marfella R; De Rosa N; Ziccardi P; Ragone R; De Angelis L; D'Onofrio F
Ann Intern Med; 1997 Jun; 126(12):955-9. PubMed ID: 9182472
[TBL] [Abstract][Full Text] [Related]
30. [A preliminary study of insulin resistance in essential hypertension, simple obesity and acromegaly].
Zhao D
Zhonghua Xin Xue Guan Bing Za Zhi; 1993 Oct; 21(5):269-71, 314. PubMed ID: 8200305
[TBL] [Abstract][Full Text] [Related]
31. [The relationship between testosterone and dehydroepiandrosterone sulfate concentrations, insulin resistance and visceral obesity in elderly men].
Rabijewski M; Kozakowski J; Zgliczyński W
Endokrynol Pol; 2005; 56(6):897-903. PubMed ID: 16821208
[TBL] [Abstract][Full Text] [Related]
32. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
Middeke M; Richter WO; Schwandt P; Holzgreve H
Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
[TBL] [Abstract][Full Text] [Related]
33. Moxonidine improves insulin sensitivity in insulin-resistant hypertensives.
Haenni A; Lithell H
J Hypertens Suppl; 1999 Aug; 17(3):S29-35. PubMed ID: 10489096
[TBL] [Abstract][Full Text] [Related]
34. Insulin resistance, dehydroepiandrosterone sulfate and sex hormone-binding globulin in essential hypertension.
Serrano-Gotarredona J; Escobar-Morreale HF; Sancho JM; García-Robles R
Horm Metab Res; 1998 Mar; 30(3):153-7. PubMed ID: 9566859
[TBL] [Abstract][Full Text] [Related]
35. A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension.
Pollare T; Lithell H; Berne C
N Engl J Med; 1989 Sep; 321(13):868-73. PubMed ID: 2671740
[TBL] [Abstract][Full Text] [Related]
36. Peripheral hyperinsulinemia of simple obesity: pancreatic hypersecretion or impaired insulin metabolism?
Bonora E; Zavaroni I; Bruschi F; Alpi O; Pezzarossa A; Guerra L; Dall'Aglio E; Coscelli C; Butturini U
J Clin Endocrinol Metab; 1984 Dec; 59(6):1121-7. PubMed ID: 6386838
[TBL] [Abstract][Full Text] [Related]
37. Metabolic effects of long-term treatments with nifedipine-retard and captopril in young hypertensive patients.
Masuo K; Mikami H; Ogihara T; Tuck ML
Am J Hypertens; 1997 Jun; 10(6):600-10. PubMed ID: 9194505
[TBL] [Abstract][Full Text] [Related]
38. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
[TBL] [Abstract][Full Text] [Related]
39. Obesity and dehydroepiandrosterone/dehydroepiandrosterone sulfate relationships in lean, obese, and meat-type cross-bred boars: responses to porcine growth hormone.
Wise T; Klindt J; Buonomo FC
Endocrinology; 1995 Aug; 136(8):3310-7. PubMed ID: 7628365
[TBL] [Abstract][Full Text] [Related]
40. Dehydroepiandrosterone sulfate levels in women. Relationships with age, body mass index and insulin levels.
Mazza E; Maccario M; Ramunni J; Gauna C; Bertagna A; Barberis AM; Patroncini S; Messina M; Ghigo E
J Endocrinol Invest; 1999 Oct; 22(9):681-7. PubMed ID: 10595831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
